View all newsletters
Idera Pharmaceuticals has revealed that the Phase III, pivotal ILLUMINATE-301 trial of tilsotolimod in combination with Bristol Myers Squibb’s Yervoy (ipilimumab) versus Yervoy alone in patients…
By
Campaigners argue the new regulations are not extensive enough where the recommendation of cannabis-based medicine for pain is concerned.
By
HIV infections can be well controlled with antiretroviral therapy to a degree where the viral load is not detectable…
By
Sickle cell disease comprises a group of inherited disorders caused by mutations of haemoglobin subunit beta.
By
84% of gene therapy trials happening in various neurology indications, listed in GlobalData’s Pharma Intelligence Center, are in early-stage…
By
The number one drug in biosimilar clinical trials by count is adalimumab biosimilar, referencing the branded biologic Humira.
By
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s Contract Service Provider Database.
ByThank you for subscribing to Clinical Trials Arena